Atherogenesis and atherothrombosis--focus on diabetes mellitus

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Pathology

Background:

• Diabetes mellitus is a leading cause of cardiovascular morbidity and mortality.
• Atherothrombosis, characterized by atherosclerotic plaque disruption and thrombus formation, underlies most deaths in diabetic patients.
• Diabetes exacerbates both microvascular and macrovascular complications, with a marked increase in risks affecting large arteries.

Purpose of the Study:

• To highlight the critical link between diabetes mellitus and atherothrombosis.
• To emphasize that atherothrombosis is the primary driver of cardiovascular mortality in diabetic individuals.
• To underscore the amplified risk of macrovascular disease in diabetes.

Main Methods:

• Review of existing literature on diabetes, atherosclerosis, and atherothrombosis.
• Analysis of epidemiological data linking diabetes to cardiovascular events.
• Pathophysiological examination of atherothrombosis development in the context of diabetes.

Main Results:

• Atherothrombosis is responsible for the majority of deaths among patients with diabetes mellitus.
• Diabetes significantly magnifies the risk of cardiovascular events, including myocardial infarction and ischemic stroke.
• The progression of atherosclerosis in diabetic patients leads to acute atherothrombotic events via plaque rupture.

Conclusions:

• Diabetes mellitus substantially elevates the risk of atherothrombosis and subsequent cardiovascular mortality.
• Effective management of diabetes is crucial for mitigating macrovascular complications.
• Understanding the atherothrombotic mechanisms in diabetes is key to preventing severe cardiovascular outcomes.